Citadel Advisors »

Nephros shares owned by Citadel Advisors

Quarter-by-quarter ownership of Nephros (NEPH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Nephros

Tip: Access up to 7 years of quarterly data

All positions including Nephros held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nephros by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $30k 17k 1.71
2024-06-30 $25k 12k 2.11
2023-03-31 $17k 15k 1.09
2022-12-31 $21k 18k 1.12
2022-06-30 $0 12k 0.00
2021-03-31 $123k 18k 6.68

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Nephros

Wexford Capital
Vanguard Group
Bard Associates
Geode Capital Management
HighTower Advisors
Elkhorn Partners Limited Partnership
William Blair $ Company
Renaissance Technologies
Citadel Advisors
State Street Corporation
Dimensional Fund Advisors
Mesirow Financial Investment Management International Equity
Morgan Stanley
Tower Research Capital
Jpmorgan Chase & Co

View all funds holding Nephros